Products

AXO Launcher

One launcher. Every home screen.

axolauncher.com Google PlayUtilities / Browser Themes & New Tabs

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Freemium model, plan pricing not identified yet
Creators
AXO
No social account linked
Launched
3mo ago
2026-08-27 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • New product launchLaunch

    Aug 27 · 3mo agoWebsite

Store data

Google Play
Google Play Google Play
Update date not synced
Rating
Rating not syncedRating count not synced
New ratings last mo
—
Price & IAP
FreeIAP data not synced
Current version
—Store metadata

Store assets, rating histograms, install tiers, and screenshots are synced from Apple App Store, Google Play, and Chrome Web Store.

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-08-27

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-13 · Source page

Pages & changes

Tracked since 2026-11-13

Key pages

Weekly snapshots
www.axolauncher.com/ Snapshot 2026-11-13

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does AXO Launcher get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is AXO Launcher and what platforms does it support?
AXO Launcher is catalogued under Browser Themes & New Tabs: One launcher. Every home screen.. Supported platforms: Mobile App.

Related products in this category

Utilities / Browser Themes & New Tabs

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.